Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,229 | -4,019 | -1,798 | -15,325 | -13,014 |
| Depreciation Amortization | 25,630 | 16,946 | 8,304 | 33,754 | 25,321 |
| Accounts receivable | -30,212 | 1,379 | -2,458 | 1,056 | 2,443 |
| Accounts payable and accrued liabilities | 5,150 | 363 | 481 | -22 | -1,886 |
| Other Working Capital | -10,391 | -6,232 | -10,490 | -27,295 | -20,185 |
| Other Operating Activity | 33,759 | 4,449 | 5,092 | 12,634 | 9,310 |
| Operating Cash Flow | $20,707 | $12,886 | $-869 | $4,802 | $1,989 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,364 | -2,241 | -1,092 | -9,194 | -7,550 |
| Net Acquisitions | N/A | N/A | N/A | -100 | -100 |
| Purchase Of Investment | N/A | N/A | N/A | -2,500 | -2,500 |
| Investing Cash Flow | $-4,364 | $-2,241 | $-1,092 | $-11,794 | $-10,150 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 452 | 452 |
| Debt Repayment | -1,255 | -831 | -413 | -1,470 | -1,107 |
| Common Stock Issued | 2,067 | 1,650 | -268 | 12,003 | 11,019 |
| Financing Cash Flow | $812 | $819 | $-681 | $10,985 | $10,364 |
| Exchange Rate Effect | -139 | -105 | 333 | 1,303 | 1,144 |
| Beginning Cash Position | 64,928 | 64,928 | 64,928 | 59,632 | 59,632 |
| End Cash Position | 81,944 | 76,287 | 62,619 | 64,928 | 62,979 |
| Net Cash Flow | $17,016 | $11,359 | $-2,309 | $5,296 | $3,347 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,707 | 12,886 | -869 | 4,802 | 1,989 |
| Capital Expenditure | -4,364 | -2,241 | -1,092 | -9,194 | -7,550 |
| Free Cash Flow | 16,343 | 10,645 | -1,961 | -4,392 | -5,561 |